STUB1 and atherosclerosis: Given CHIP’s well-established role in atherosclerosis and large-vessel cardiovascular disease, it is reasonable to hypothesize that similar mechanisms extend to the cerebral microvasculature, potentially promoting small vessel pathology, white matter damage, and cognitive decline.